Isabelle Bar
Overview
Explore the profile of Isabelle Bar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
609
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Roumeguere T, Noyon C, Van Antwerpen P, Poelvoorde P, Bar I, Abdulsater F, et al.
Inflammation
. 2023 Jun;
46(5):1859-1870.
PMID: 37318620
Myeloperoxidase (MPO) has been reported in prostate tissue, and considering its pro-oxidant properties, this location might be linked to prostate pathology. The possibility that the glandular prostatic tissue might be...
2.
van Marcke C, Helaers R, De Leener A, Merhi A, Schoonjans C, Ambroise J, et al.
Breast Cancer Res
. 2020 Apr;
22(1):36.
PMID: 32295625
Background: Multigene panels are routinely used to assess for predisposing germline mutations in families at high breast cancer risk. The number of variants of unknown significance thereby identified increases with...
3.
De Keersmaecker B, Claerhout S, Carrasco J, Bar I, Corthals J, Wilgenhof S, et al.
J Immunother Cancer
. 2020 Mar;
8(1).
PMID: 32114500
Background: We previously reported that dendritic cell-based mRNA vaccination plus ipilimumab (TriMixDC-MEL IPI) results in an encouraging rate of tumor responses in patients with pretreated advanced melanoma. Here, we report...
4.
Bar I, Theate I, Haussy S, Beniuga G, Carrasco J, Canon J, et al.
J Histochem Cytochem
. 2019 Dec;
68(1):25-32.
PMID: 31787032
Triple-negative breast cancer (TNBC) is a heterogeneous group of breast cancer and is characterized by aggressiveness and poor prognosis. MicroRNA represents a new class of biomarkers, and accumulating evidence indicates...
5.
Bar I, Merhi A, Larbanoix L, Constant M, Haussy S, Laurent S, et al.
Oncotarget
. 2018 Aug;
9(56):30821-30836.
PMID: 30112110
The casein kinase 1 delta (CSNK1D) is a conserved serine/threonine protein kinase that regulates diverse cellular processes including cell cycle progression, circadian rhythm, and neurite outgrowth. Aberrant expression of CSNK1D...
6.
Bar I, Merhi A, Abdel-Sater F, Ben Addi A, Sollennita S, Canon J, et al.
J Histochem Cytochem
. 2017 Apr;
65(6):335-346.
PMID: 28402752
The triple-negative breast cancer (TNBC) subtype occurs in about 15% of breast cancer and is an aggressive subtype of breast cancer with poor outcome. Furthermore, treatment of patients with TNBC...
7.
Dequanter D, Van de Velde M, Bar I, Nuyens V, Rousseau A, Nagy N, et al.
Oncol Lett
. 2016 Jun;
11(6):3660-3668.
PMID: 27284370
Glutathione (GSH) is the keystone of the cellular response toward oxidative stress. Elevated GSH content correlates with increased resistance to chemotherapy and radiotherapy of head and neck (HN) tumors. The...
8.
Chidiac M, Fayyad-Kazan M, Daher J, Poelvoorde P, Bar I, Maenhaut C, et al.
Pathol Res Pract
. 2016 May;
212(7):631-5.
PMID: 27157405
The apolipoprotein L (apoL) family has not yet been ascribed any definite patho-physiological function although the conserved BH3 protein domain suggests a role in programmed cell death. As repression of...
9.
Toffoli S, Bar I, Abdel-Sater F, Delree P, Hilbert P, Cavallin F, et al.
Breast Cancer Res
. 2014 Nov;
16(6):466.
PMID: 25416589
Introduction: Triple Negative Breast Cancers (TNBC) represent about 12% to 20% of all breast cancers (BC) and have a worse outcome compared to other BC subtypes. TNBC often show a...
10.
Saulnier A, Keruzore M, De Clercq S, Bar I, Moers V, Magnani D, et al.
Cereb Cortex
. 2012 Aug;
23(11):2552-67.
PMID: 22923088
Regional patterning of the cerebral cortex is initiated by morphogens secreted by patterning centers that establish graded expression of transcription factors within cortical progenitors. Here, we show that Dmrt5 is...